Skip to main content
OpenTrials
Completed

NCT Number: NCT01149512

Outcomes of the Adjustable Gastric Band in a Publicly Funded Obesity Program

The majority of data documenting the outcomes for the adjustable gastric band (LAGB) originate from non-publicly funded surgical centres. The investigators aim to investigate the clinical outcomes of LAGB from a publicly funded Canadian obesity management program. This program recognized obesity as a chronic disease, providing extensive pre-operative multidisciplinary assessment and long term patient follow-up. Patients are selected for surgical management carefully by a multidisciplinary team and the LAGB is presented as one option to surgical management. Further, the investigators will investigate the operational impacts, including direct and indirect costs related the LAGB, to determine long term impacts on publicly funded hospitals within Canada.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Morbid Obesity Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Obesity Obesity, Morbid Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Center for the Advancement of Minimally Invasive Surgery & Weight Wise Program

Edmonton, Alberta, T5H 3V9, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients seen within the Weight Wise program and selected for surgical management, who have undergone LAGB will be included in this analysis.

Exclusion criteria

  • Patients who have undergone selection for surgery outside this process, or who have had surgery elsewhere.

Treatment and study plan

Primary outcomes

  1. Mean Percentage Total Body Weight Loss

    Time frame: baseline to 1 year, baseline to 2 years, baseline to 3 years

    the percent total body weight loss between Baseline and 1 year the percent total body weight loss between Baseline and 2 years the percent total body weight loss between Baseline and 3 years

Secondary outcomes

  1. % of Excess Body Weight Loss

    Time frame: baseline to 1 year, baseline to 2 years, baseline to 3 years

    the percent of excess body weight loss between Baseline and 1 year the percent of excess body weight loss between Baseline and 2 years the percent of excess body weight loss between Baseline and 3 years

Sponsors and collaborators

Lead sponsor

University of Alberta

Other

Collaborators

  • Alberta Health services

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jun 23, 2010
Registry last updated
Sep 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.